Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Huarong International Financial | Hong Kong | Financial | Investment Banking & Investment Services | HK$1.72B | -4.6x | -0.08 | HK$0.21 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fengyinhe Holdings | Hong Kong | Financial | Investment Banking & Investment Services | HK$332.44M | 0.9x | -0.21 | HK$1.02 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Holly Futures Co | Hong Kong | Financial | Investment Banking & Investment Services | HK$2.73B | 109.1x | 1.7 | HK$2.71 | -5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Capital VC | Hong Kong | Financial | Investment Banking & Investment Services | HK$106.23M | -1.4x | -0.06 | HK$0.24 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ARTA TechFin | Hong Kong | Financial | Investment Banking & Investment Services | HK$784.87M | -13.7x | -0.37 | HK$0.04 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Everest Med | Hong Kong | Healthcare | Pharmaceuticals | HK$2.44B | -6.2x | HK$35.15 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Abbisko Cayman | Hong Kong | Healthcare | Biotechnology & Medical Research | HK$2.78B | -121.8x | -1.81 | HK$4.35 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tong Tong AI Social | Hong Kong | Financial | Banking Services | HK$1.69B | 16x | 0.04 | HK$0.31 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Trip.com Group | Hong Kong | Consumer Cyclicals | Hotels & Entertainment Services | HK$303.71B | 16.1x | 0.18 | HK$468 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | |
Ascentage Pharma | Hong Kong | Healthcare | Biotechnology & Medical Research | HK$12.97B | -34.3x | -0.56 | HK$42.50 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
Sands China | Hong Kong | Consumer Cyclicals | Hotels & Entertainment Services | HK$153.94B | 18.7x | 0.08 | HK$19.04 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.6% Upside | Upgrade to Pro+ | |
Capital Estate | Hong Kong | Financial | Investment Banking & Investment Services | HK$76.76M | 13.8x | 0.12 | HK$0.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Remegen | Hong Kong | Healthcare | Biotechnology & Medical Research | HK$15.91B | -6.1x | 0.59 | HK$17.14 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.9% Upside | Upgrade to Pro+ | |
Melco Int Development | Hong Kong | Consumer Cyclicals | Hotels & Entertainment Services | HK$7.23B | -5.7x | -0.1 | HK$4.76 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.9% Upside | Upgrade to Pro+ | |
OSL | Hong Kong | Technology | Financial Technology (Fintech) & Infrastructure | HK$4.29B | -18.9x | -0.51 | HK$6.72 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.7% Downside | Upgrade to Pro+ | |
DT Capital | Hong Kong | Financial | Investment Holding Companies | HK$194.20M | -24x | -0.34 | HK$0.07 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Galaxy Entertainment Group | Hong Kong | Consumer Cyclicals | Hotels & Entertainment Services | HK$142.92B | 17.2x | 0.01 | HK$32.65 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.2% Upside | Upgrade to Pro+ | |
Beigene | Hong Kong | Healthcare | Biotechnology & Medical Research | HK$12.11B | -24.6x | -0.6 | HK$113.90 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.2% Upside | Upgrade to Pro+ | |
Dynamic | Hong Kong | Real Estate | Real Estate Operations | HK$1.77B | 0.3x | 0 | HK$7.46 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
China Merchants China Direct | Hong Kong | Financial | Investment Banking & Investment Services | HK$2.11B | 178.6x | 1.68 | HK$13.86 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zhaoke Ophthalmology | Hong Kong | Healthcare | Pharmaceuticals | HK$753.67M | -3.1x | -0.06 | HK$1.40 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
China Graphene | Hong Kong | Real Estate | Real Estate Operations | HK$489.16M | 25.7x | 0.51 | HK$0.08 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AUSupreme Intl | Hong Kong | Consumer Cyclicals | Specialty Retailers | HK$171.45M | 5.6x | 0 | HK$0.22 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yinsheng Digifavor | Hong Kong | Technology | Telecommunications Services | HK$1.21B | 30.6x | 0.16 | HK$2.94 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LFG Investment Holdings | Hong Kong | Financial | Investment Banking & Investment Services | HK$76.73M | -19.4x | -0.24 | HK$0.18 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orient Securities Int | Hong Kong | Financial | Banking Services | HK$19.49M | 6.9x | 0.07 | HK$0.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sunwah Kingsway Capital | Hong Kong | Financial | Investment Banking & Investment Services | HK$165.28M | -2.9x | -0.1 | HK$0.22 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Safety Godown | Hong Kong | Real Estate | Real Estate Operations | HK$741.15M | -6x | -0.18 | HK$1.83 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mabpharm | Hong Kong | Healthcare | Biotechnology & Medical Research | HK$1.22B | -5.9x | 0.97 | HK$0.34 | 13.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Wealthink AI Innovation Capital | Hong Kong | Financial | Investment Banking & Investment Services | HK$988.91M | 18.8x | -0.27 | HK$0.09 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |